Dr. Holland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St.
MC0960
Denver, CO 80204Phone+1 303-602-3899
Summary
- Matthew Holland, MD is a Cardiologist based in Denver, CO, with subspecialties in Interventional Cardiology and Peripheral Endovascular Interventional Cardiology. He completed his degree and residency in Internal Medicine at Johns Hopkins University School of Medicine, then pursued a Fellowship in Cardiovascular Disease at the University of Utah Health. He has experience in treating valvular heart disease, performing cardiac catheterization, limb salvage angioplasty, and minimally invasive cardiac surgery. He has several notable publications in the field. Dr. Holland has been recognized as a Fellow by the American College of Cardiology, has the FSCAI credential, and has received the CMS Meaningful Use Stage 1 Certification by NextGen Healthcare.
Education & Training
- University of Utah HealthFellowship, Cardiovascular Disease, 1988 - 1992
- Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
- Johns Hopkins University School of MedicineClass of 1985
Certifications & Licensure
- CO State Medical License 1995 - 2025
- UT State Medical License 1988 - 1998
- NM State Medical License 1992 - 1996
- MD State Medical License 1987 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- FSCAI
- Fellow (FACC) American College of Cardiology
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Clinical Trials
- Diagnosing Adverse Drug Reactions Registry Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 15 citationsExcess Cardiac Arrest in the Community During the COVID-19 Pandemic.Matthew R Holland, Joseph Burke, Steven Hulac, Michael Morris, Gary Bryskiewicz
JACC. Cardiovascular Interventions. 2020-08-24 - 5 citationsTransesophageal echocardiographically guided angiography of an anomalous coronary arteryDarius Aliabadi, Milton Icenogle, Sarah Samaan, Carlos Roldan, Matthew Holland
American Heart Journal. 1995-01-01 - 5 citationsCardiovascular effects of platelet-activating factor.Matthew R. Holland, Thomas M. McIntyre, Guy A. Zimmerman, Stephen M. Prescott
Trends in Cardiovascular Medicine. 1991-04-01
Press Mentions
- Using Serranator® in Challenging CLTI CasesMay 31st, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: